Skip to main content

Maze Therapeutics, Inc 10-Q for FY2025 Q3

Maze Therapeutics, Inc. (MAZE)

10-Q 2025-11-06 For: 2025-09-30
View Original
Added on April 07, 2026

About this 10-Q

Maze Therapeutics, Inc filed this 10-Q on November 6, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).

Headline figures

Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$30.09M
compared with a net loss of $24.75M a year earlier
Diluted EPS
-$0.66
compared with -$10.25 a year earlier